Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

HKG/9606 stock hub

HKG/9606 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/9606is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

23.1B

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/9606

In the news

Latest news · HKG/9606

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11.7P50 18.9P75 41.4

Trailing P/En/a

P25 10.7P50 17.9P75 38.5

ROE-1,282.1

P25 -14.7P50 2P75 9.4

ROIC-102.7

P25 -10.4P50 1.9P75 10.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/9606 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

168

Groups with data

Currency

CNY

Showing 168 of 168 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Cayman Islands
Country code	HK
Employees	231
Employees Change	61%
Employees Change Percent	35.88
Enterprise value	HKD 19.5B
Exchange	Hong Kong Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Biotechnology
Isin	KYG2929M1087
Last refreshed	2026-05-10
Market cap	HKD 23.1B
Price	HKD 256
Price currency	HKD
Rev Per Employee	8,920,474.83x
Sector	Healthcare
Sic	2836
Symbol	hkg/9606
Website	https://www.dualitybiologics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-12.49%
EV Earnings	-6.76x
EV/FCF	95.84x
EV/Sales	9.48x
FCF yield	0.88%
P/B ratio	8.56x
P/S ratio	11.22x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-24.85%
EBITDA Margin	-24.45%
FCF margin	9.89%
Gross margin	31.81%
Gross Profit	HKD 655.5M
Gross Profit Growth	-26.9%
Net Income	HKD -2.9B
Net Income Growth Years	0%
Pretax Margin	-140.13%
Profit Margin	-140.13%
Profit Per Employee	HKD -12.5M
ROA	-9.61
ROCE	-16.2
ROE	-1,282.1
ROIC	-102.7

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	27.38%
EPS Growth Years	0
FCF Growth	-35.01%
OCF Growth	-31.91%
Revenue Growth	-4.61x
Revenue Growth Q	-33.85x
Revenue Growth Quarters	2x
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	HKD 0.62
Assets	HKD 4.3B
Cash	HKD 3.8B
Current Assets	HKD 4.4B
Current Liabilities	HKD 1.2B
Debt	HKD 166.7M
Debt Equity	HKD 0.06
Debt FCF	HKD 0.82
Equity	HKD 2.7B
Interest Coverage	-380.3
Liabilities	HKD 1.6B
Long Term Assets	HKD -83.2M
Long Term Liabilities	HKD 420.3M
Net Cash	HKD 3.6B
Net Cash By Market Cap	HKD 15.55
Net Cash Growth	132.13%
Net Debt Equity	HKD -1.33
Net Debt FCF	HKD -17.65
Tangible Book Value	HKD 2.7B
Tangible Book Value Per Share	HKD 30.15

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.65
Net Working Capital	HKD -503.1M
Quick ratio	3.52
Working Capital	HKD 3.1B
Working Capital Turnover	HKD 5.02

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-714.45%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	27.36%
200-day SMA	328.3
50-day SMA	294
50-day SMA vs 200-day SMA	50under200
All Time High	563.5
All Time High Change	-54.57%
All Time High Date	2025-09-12
All Time Low	165.5
All Time Low Change	54.68%
All Time Low Date	2025-05-12
ATR	16.21
Beta1y	1.39
Beta2y	1.4
Ch YTD	-14.15
High	259.2
High52	563.5
High52 Date	2025-09-12
High52ch	-54.57%
Low	250.8
Low52	165.5
Low52 Date	2025-05-12
Low52ch	54.68%
Ma50ch	-12.93%
Price vs 200-day SMA	-22.02%
RSI	33.81
RSI Monthly	0
RSI Weekly	41.25
Sharpe ratio	0.55x
Sortino ratio	0.96
Total Return	-714.45%
Tr YTD	-14.15
Tr1m	-20.89%
Tr1w	-6.36%
Tr3m	-18.73%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD -512M
Operating margin	-24.85

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	50,960,170%
Net Borrowing	157,329,998.8
Shares Insiders	12.73%
Shares Institutions	36.13%
Shares Out	90,313,014
Shares Qo Q	112.47%
Shares Yo Y	714.45%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	HKD 30.1M
Average Volume	719,651.5x
Bv Per Share	30.2
CAPEX	HKD -12.8M
Ch1m	-20.89
Ch1w	-6.36
Ch1y	27.36
Ch3m	-18.73
Ch6m	-10.18
Change	-1.46%
Change From Open	-0.85
Close	259.8
Days Gap	-0.62
Depreciation Amortization	8,551,507.2
Dollar Volume	150,272,768
Earnings Date	2026-03-23
EBIT	HKD -512M
EBITDA	HKD -503.8M
EPS	HKD -44.32
F Score	2
FCF	HKD 203.7M
FCF EV Yield	1.04x
FCF Per Share	HKD 2.26
Financing CF	2,012,861,192
Fiscal Year End	December
Founded	2,019
Investing CF	-2,128,327,496
Is Primary Listing	1
Last Earnings Date	2026-03-23
Last Report Date	2025-12-31
Ma150	315.4
Ma150ch	-18.84%
Ma20	288.6
Ma20ch	-11.3%
Net CF	75,106,902
Open	258.2
P FCF Ratio	113.5
P OCF Ratio	106.8
Position In Range	61.9
Ppne	33,021,070.5
Price Date	2026-05-08
Ptbv Ratio	8.58
Relative Volume	0.8x
Revenue	2,060,629,685x
SBC By Revenue	8.43x
Share Based Comp	173,652,926
Tr6m	-10.18%
Volume	587,003
Z Score	9.2

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does HKG/9606 pay a dividend?

Capital-return profile for this ticker.

Performance

HKG/9606 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HKG/9606?

Insider, institutional, and short-interest positioning.

Institutional ownership

+36.1%

Share of float held by funds and institutions

Insider ownership

+12.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+714.4%

Negative means the company is buying back shares.

Technical

HKG/9606 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

33.8

Neutral momentum band

Price vs 200-day MA

-22.0%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.55

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/9606

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/9606 stock rating?

hkg/9606 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/9606 analysis?

The full report lives at /stocks/hkg/9606/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/9606?

The latest report frames hkg/9606 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/9606 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.